Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes

<p>(a) Amino acid sequences of the five apoAII isoforms (ApoAII-ATQ/ATQ, -ATQ/AT, -AT/AT, -AT/A, and -A/A). Two peptides were dimerized via an N-terminal disulfide bond. (b) Direction of proteolytic digestion (long arrow) and the alteration of the isoforms (box arrows) in hyper- and hypoprocessing patterns (originally produced according to [<a href="/journals/bmri/2019/5738614/#B4">4</a>]).</p>

BioMed Research International

fig1

Figure 1

Figure 1: Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes 

Figure 1 | Clinical Significance of Plasma Apolipoprotein-AII Isoforms as a Marker of Pancreatic Exocrine Disorder for Patients with Pancreatic Adenocarcinoma Undergoing Chemoradiotherapy, Paying Attention to Pancreatic Morphological Changes 